Dr. Christina Vetsch-Tzogiou

Work at ZHAW

Position

Co-Head HTA and Health Economic Evaluations

Focus

Applied health economics, Health Technology Assessments (HTA), health economic evaluations, inequalities in health and health care, health economic aspects of migration

Teaching

• BSc Gesundheitsförderung und Prävention
• MAS Managed Health Care
• CAS Gesundheitsökonomische Evaluationen und HTA
• PhD Seminar on Health Economics

Experience

• Co-Head HTA and Health Economic Evaluations
  WIG, ZHAW
  06 / 2024 - today
• Senior research associate
  WIG, ZHAW
  10 / 2014 - 05 / 2024
• Research assistant
  Swiss Institute for International Economics and Applied Economic Research, University of St.Gallen
  05 / 2013 - 05 / 2014

Education and Continuing education

Education

• PhD / Health Sciences
  University of Lucerne
  2016 - 2022
• International Doctoral Courses in Health Economics and Policy / Health Economics
  SSPH+
  2016 - 2018
• MA HSG / Economics
  University of St. Gallen
  2011 - 2014
• BS / Economics
  University of Piraeus
  2006 - 2011

Continuing Education

• Integration Module in Medicine for None-Medical Professionals
  ZHAW
  2015
• CAS in Evidence-Based Health Economics
  ZHAW
  2015

Network

Membership of networks

• European Health Economics Association EuHEA
• International Health Economics Association iHEA
• Swiss Society of Health Economics SGGÖ
• Swiss Network for Health Technology Assessment SNHTA
• Swiss School of Public Health SSPH+
• International Migration, Integration and Social Cohesion in Europe IMISCOE

ORCID digital identifier

ORCID ID: 0000-0001-8100-0034

Projects

• Medicines containing valerian for treating symptoms of insomnia, mental stress and test anxiety / Co-project leader / completed
• Clinical Evidence Synthesis Report: Oseltamivir and baloxavir marboxil to treat or prevent influenza A and B / Project leader / completed
• Costs of communicable and non-communicable diseases and of the risk factors physical inactivity and overweight in Switzerland / Team member / completed
• Health Technology Assessment: Medicines for Dementia due to Alzheimer's and Parkinson's Disease / Team member / completed
• Integration of Vulnerable Groups in the Healthcare System / Co-project leader / completed
• The societal costs of Cystic Fibrosis in Switzerland / Team member / completed
• Health Technology Assessment: Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2 / Team member / completed
• Incidence and costs of hypoglycemia in insulin-treated diabetes mellitus in Switzerland / Team member / completed
• Burden of micronutrient deficiencies and cost-effectiveness of interventions with fortified foods / Team member / completed

Publications

Articles in scientific journal, peer-reviewed

• Tzogiou, C. et al. (2023) 'Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis', Journal of Diabetes and its Complications, 37(6), p. 108476. doi: 10.1016/j.jdiacomp.2023.108476.
• Tzogiou, C. et al. (2022) 'Detecting and describing heterogeneity in health care cost trajectories among asylum seekers', BMC Health Services Research, 22(978). doi: 10.1186/s12913-022-08346-y.
• Tzogiou, C., Boes, S. and Brunner, B. (2021) 'What explains the inequalities in health care utilization between immigrants and non-migrants in Switzerland?', BMC Public Health, 21(530). doi: 10.1186/s12889-021-10393-9.
• Wieser, S. et al. (2018) 'Reducing micronutrient deficiencies in Pakistani children : are subsidies on fortified complementary foods cost-effective?', Public Health Nutrition, 21(15), pp. 2893–2906. doi: 10.1017/S1368980018001660.
• Wieser, S. et al. (2017) 'Societal costs of micronutrient deficiencies in 6- to 59-month-old children in Pakistan', Food and Nutrition Bulletin, 38(4), pp. 485–500. doi: 10.1177/0379572117720012.
• Plessow, R. et al. (2015) 'Social costs of iron deficiency anemia in 6–59-month-old children in India', PLOS ONE, 10(8), pp. 1–16. doi: 10.1371/journal.pone.0136581.

Book chapters, peer-reviewed

• Wieser, S. et al. (2025) 'Kosten und Finanzierung', in Psychische Gesundheit in der Schweiz: Entwicklung, Förderung, Prävention und Versorgung : Nationaler Gesundheitsbericht 2025. Neuchâtel: Bundesamt für Statistik BFS, pp. 404–433. Available at: https://www.obsan.admin.ch/sites/default/files/2025-09/ngb2025_de.pdf.
• Wieser, S. and Tzogiou, C. (2017) 'Does it work? Is it worth it? : evaluating the costs and benefits of nutritional interventions', in Biesalski, H. K. et al. (eds) Sustainable nutrition in a changing world. Cham: Springer, pp. 343–353. doi: 10.1007/978-3-319-55942-1_27.

Written conference contributions, peer-reviewed

• Vetsch-Tzogiou, C. et al. (2024) 'Should we stop paying for the old dementia drugs? : a cost-utility and budget impact analysis', in EuHEA Conference, Vienna, Austria, 30 June - 3 July 2024.
• Vetsch-Tzogiou, C. et al. (2024) 'Medicines for dementia due to Alzheimer's and Parkinson's disease', in HTAi 2024 Annual Meeting, Seville, Spain, 15-19 June 2024.
• Bürgin, R. et al. (2024) 'Improving risk adjustment in Switzerland with pharmaceutical cost groups', in 6th Swiss Health Economic Workshop, Lucerne, Switzerland, 7 June 2024.

Other publications

• Stucki, M. et al. (2025) Kosten der übertragbaren und nichtübertragbaren Krankheiten sowie Kosten der Risikofaktoren Übergewicht/Adipositas und Bewegungsmangel in der Schweiz. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-34672.
• Vetsch-Tzogiou, C. et al. (2025) Oseltamivir and baloxavir marboxil to treat or prevent influenza A and B. Bern: Federal Office of Public Health FOPH. Available at: https://www.bag.admin.ch/dam/en/sd-web/hkgFTLg65Zo8/h0087tflu-hta-report.pdf.
• Bürgin, R. et al. (2024) Wirkungsanalyse zum Risikoausgleich mit pharmazeutischen Kostengruppen (PCG) : Schlussbericht. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-30489.
• Vetsch-Tzogiou, C. (2023) 'Die hohe Krankheitslast der Hypoglykämie in der Schweiz', Gesundheitsökonomie @ ZHAW. Available at: https://blog.zhaw.ch/gesundheitsoekonomie/2023/06/29/die-hohe-krankheitslast-der-hypoglykaemie-in-der-schweiz/.
• Tzogiou, C. (2023) 'Wie verlaufen die Gesundheitskosten von Asylbewerbenden?', Gesundheitsökonomie @ ZHAW. Available at: https://blog.zhaw.ch/gesundheitsoekonomie/2023/03/23/wie-verlaufen-die-gesundheitskosten-von-asylbewerbenden/.
• Tzogiou, C. and Vinci, L. (2023) 'Was bringen die Medikamente gegen Demenz bei Alzheimer und Parkinson?', Gesundheitsökonomie @ ZHAW. Available at: https://blog.zhaw.ch/gesundheitsoekonomie/2023/02/16/was-bringen-die-medikamente-gegen-demenz-bei-alzheimer-und-parkinson/.
• Mattli, R. et al. (2022) Health technology assessment (HTA) : medicines for dementia due to Alzheimer's and Parkinson's disease. Bern: Bundesamt für Gesundheit BAG. Available at: https://www.bag.admin.ch/dam/en/sd-web/59GbzBb6Io0A/h0048alzh-hta-report.pdf.
• Tzogiou, C. and Mattli, R. (2022) 'Kosten-Wirksamkeit, Krankheitslast und Budget Impact von Inclisiran', Gesundheitsökonomie @ ZHAW. Available at: https://blog.zhaw.ch/gesundheitsoekonomie/2022/06/30/kosten-wirksamkeit-krankheitslast-und-budget-impact-von-inclisiran/.
• Mattli, R. et al. (2021) 'Wie wirkt sich Cystische Fibrose auf Betroffene und Gesellschaft aus?', ensemble, 2021(2), pp. 22–24. Available at: https://cystischefibroseschweiz.ch/media/files/2022/03/Ensemble_02_Deutsch.pdf.
• Tzogiou, C. et al. (2021) 'Health inequalities and risk factors of inadequate health care among vulnerable groups : children, elderly with chronic conditions, and immigrants', in Swiss Public Health Conference, Bern, 25.-26. August 2021. Available at: https://sphc21.ispm.ch/wp-content/uploads/sites/2/2021/08/SPHC_2021_Poster_Carlander.pdf.
• Tzogiou, C., Brunner, B. and Boes, S. (2021) 'The immigration-specific determinants of health care utilization : a Swiss cross-sectional study', in iHEA 2021 Congress, virtual, 12-15 July 2021.
• Tzogiou, C. et al. (2021) 'The burden of cystic fibrosis beyond medical costs in Switzerland', in 44th European Cystic Fibrosis Conference, digital, 9-12 June 2021.
• Tzogiou, C. and Mattli, R. (2021) 'Wie wirkt sich Cystische Fibrose auf Betroffene und Gesellschaft aus?', Gesundheitsökonomie @ ZHAW. Available at: https://blog.zhaw.ch/gesundheitsoekonomie/2021/12/02/wie-wirkt-sich-cystische-fibrose-auf-betroffene-und-gesellschaft-aus/.
• Carlander, M. et al. (2020) 'The use of pediatric health care services in Switzerland : a claims data analysis (preliminary results)', in Swiss Public Health Conference 2020 : «From Evidence to Public Health Policy and Practice», Virtual Conference, 2-3 September 2020. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. doi: 10.21256/zhaw-22369.
• Carlander, M. et al. (2020) 'The use of pediatric health care services in Switzerland : a claims data analysis (preliminary results)', in 19. Deutscher Kongress für Versorgungsforschung, Online, 30. September - 1. Oktober 2020. doi: 10.3205/20dkvf436.
• Tzogiou, C., Pöhlmann, J. and Mattli, R. (2020) Die gesellschaftlichen Kosten der cystischen Fibrose in der Schweiz : eine umfangreiche Krankheitskostenstudie. Bern: Schweizerische Gesellschaft für Cystische Fibrose (CFCH).
• Tzogiou, C. and Brunner, B. (2020) The immigration-specific determinants of health care utilization in vulnerable immigrants : a Swiss cross-sectional study : Lecture held at PHD/Master Seminar, University of Lucerne/Department of Health Sciences and Medicine, 2. November 2020.
• Eichler, K. et al. (2019) Health technology assessment : self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2. Bundesamt für Gesundheit. doi: 10.21256/zhaw-19405.
• Tzogiou, C., Boes, S. and Brunner, B. (2019) What explains the inequalities in healthcare use between immigrants and natives in Switzerland? : Lecture held at Research Seminar in Health Sciences, University of Lucerne/Department of Health Sciences and Medicine, 8 April 2019.
• Wieser, S. et al. (2016) 'Societal costs of micronutrient deficiencies in 6-59-month-old children in Pakistan', in Micronutrient Forum Global Conference, Cancun, Mexico, 23 - 28 October 2016.
• Wieser, S. et al. (2016) 'Does it work? Is it worth it? Evaluating the costs and benefits of micro-nutritional interventions', in Micronutrient Forum Global Conference, Cancun, Mexico, 23 - 28 October 2016.
• Brunner, B. et al. (2016) 'Impact of maternal malnutrition on child health : what do we know about its social costs and the cost-effectiveness of food-fortification?', in Micronutrient Forum Global Conference, Cancun, Mexico, 23 - 28 October 2016.
• Wieser, S. et al. (2016) 'Reducing micronutrient deficiencies in Pakistan : cost-effectiveness of subsidies on fortified packaged complementary food', in Micronutrient Forum Global Conference, Cancun, Mexico, 23-28 October 2016.
• Wieser, S. et al. (2015) 'Impact of hypoglycemic events occurring in diabetic patients treated with insulin in Switzerland : a health-economic analysis', in 4. Symposium zur Versorgungsforschung im Gesundheitswesen, Bern, 9. November 2015.

Oral conference contributions and abstracts

• Wieser, S. et al. (2025) 'Beyond health care spending : drivers of health-related production losses in Switzerland', in 16th IHEA World Congress on Health Economics, Bali, Indonesia, 19-23 July 2025.
• Tzogiou, C. et al. (2022) 'Detecting and describing heterogeneity in health care cost trajectories among asylum seekers', in 13th EuHEA Conference, Oslo, Norway, 5-8 July 2022.
• Carlander, M. et al. (2022) 'Adequate use of pediatric primary health care during the first three years of life in Switzerland : an analysis using claims data', in 13th EuHEA Conference, Oslo, Norway, 5-8 July 2022.
• Tzogiou, C. et al. (2021) 'Health technology assessment : self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2', in HTAi 2021 Annual Meeting, virtual, 19-23 June 2021.
• Tzogiou, C., Brunner, B. and Boes, S. (2021) 'Understanding health care utilization of immigrants in Switzerland : the role of immigrant-specific factors', in Swiss Public Health Conference, Bern, 25.-26. August 2021.
• Carlander, M. et al. (2021) 'Pediatric consultations and health status among children and adolescents in Switzerland', in 20. Deutscher Kongress für Versorgungsforschung, digital, 6.-8. Oktober 2021. doi: 10.3205/21dkvf133.
• Tzogiou, C., Boes, S. and Brunner, B. (2019) 'What explains the inequalities in healthcare use between immigrants and natives in Switzerland?', in iHEA 2019 World Congress on Health Economics, Basel, Switzerland, 13-17 July 2019.
• Tzogiou, C. (2018) 'Die Treiber der gesundheitlichen Ungleichheiten zwischen der Migrationsbevölkerung und Einheimischen in der Schweiz', in 3. Nationale Tagung «Gesundheit & Armut», Bern, 22. Juni 2018.
• Tzogiou, C. and Boes, S. (2018) 'Decomposition of health inequalities between immigrants and natives in Switzerland', in 15th International Migration, Integration and Social Cohesion IMISCOE Annual Conference, Barcelona, Spain, 2-4 July 2018.
• Tzogiou, C. and Boes, S. (2017) 'Driving factors of health inequalities between immigrants and natives in Switzerland : a decomposition analysis', in 2017 International Health Economics Association (iHEA) Biennial World Congress, Boston, USA, 8-11 July 2017.
• Wieser, S. et al. (2016) 'Costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis', in EuHEA Conference 2016: "Know the Ropes - Balancing Costs and Quality in Health Care", Hamburg, 13 to 16 July 2016.
• Wieser, S. et al. (2016) 'Costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis', in Mt Hood Diabetes Challenge 2016, St. Gallen, 17 September 2016.

go back